Zhou Z - Search Results

1

Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.

Zhou Z, Lafleur EA, Koshkina NV, Worth LL, Lester MS, Kleinerman ES. Zhou Z, et al. Mol Cancer Res. 2005 Dec;3(12):685-91. doi: 10.1158/1541-7786.MCR-05-0092. Mol Cancer Res. 2005. PMID: 16380506 Free article.

2

Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector.

Jia SF, Worth LL, Densmore CL, Xu B, Zhou Z, Kleinerman ES. Jia SF, et al. Among authors: zhou z. Cancer Gene Ther. 2002 Mar;9(3):260-6. doi: 10.1038/sj.cgt.7700432. Cancer Gene Ther. 2002. PMID: 11896442

3

Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.

Zhou RR, Jia SF, Zhou Z, Wang Y, Bucana CD, Kleinerman ES. Zhou RR, et al. Among authors: zhou z. Cancer Gene Ther. 2002 May;9(5):407-13. doi: 10.1038/sj.cgt.7700449. Cancer Gene Ther. 2002. PMID: 11961663

4

E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model.

Zhou Z, Zhou RR, Guan H, Bucana CD, Kleinerman ES. Zhou Z, et al. Among authors: zhou rr. Mol Cancer Ther. 2003 Dec;2(12):1313-9. Mol Cancer Ther. 2003. PMID: 14707272

5

Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway.

Duan X, Zhou Z, Jia SF, Colvin M, Lafleur EA, Kleinerman ES. Duan X, et al. Among authors: zhou z. Clin Cancer Res. 2004 Jan 15;10(2):777-83. doi: 10.1158/1078-0432.ccr-1245-02. Clin Cancer Res. 2004. PMID: 14760101

6

Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.

Cao Y, Zhou Z, de Crombrugghe B, Nakashima K, Guan H, Duan X, Jia SF, Kleinerman ES. Cao Y, et al. Among authors: zhou z. Cancer Res. 2005 Feb 15;65(4):1124-8. doi: 10.1158/0008-5472.CAN-04-2128. Cancer Res. 2005. PMID: 15734992

7

Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.

Guan H, Jia SF, Zhou Z, Stewart J, Kleinerman ES. Guan H, et al. Among authors: zhou z. Clin Cancer Res. 2005 Mar 1;11(5):2008-17. doi: 10.1158/1078-0432.CCR-04-0777. Clin Cancer Res. 2005. PMID: 15756027

8

A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.

Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES. Guan H, et al. Among authors: zhou z. Clin Cancer Res. 2005 Apr 1;11(7):2662-9. doi: 10.1158/1078-0432.CCR-04-1206. Clin Cancer Res. 2005. PMID: 15814647

9

E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.

Zhou Z, Guan H, Kleinerman ES. Zhou Z, et al. Mol Cancer Res. 2005 May;3(5):271-5. doi: 10.1158/1541-7786.MCR-04-0179. Mol Cancer Res. 2005. PMID: 15886298 Free article.

10

Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.

Zhou Z, Guan H, Duan X, Kleinerman ES. Zhou Z, et al. Cancer. 2005 Oct 15;104(8):1713-20. doi: 10.1002/cncr.21383. Cancer. 2005. PMID: 16121404 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,703 results

Search Page

Filters